Comprehensive serological analysis of two successive heterologous vaccines against H5N1 avian influenza virus in exotic birds in zoos.
Identifieur interne : 000415 ( Main/Exploration ); précédent : 000414; suivant : 000416Comprehensive serological analysis of two successive heterologous vaccines against H5N1 avian influenza virus in exotic birds in zoos.
Auteurs : Júlia Vergara-Alert [Espagne] ; Hugo Fernández-Bellon ; Núria Busquets ; Gabriel Alcántara ; María Delclaux ; Bienvenido Pizarro ; Celia Sánchez ; Azucena Sánchez ; Natàlia Maj ; Ayub DarjiSource :
- Clinical and vaccine immunology : CVI [ 1556-679X ] ; 2011.
Descripteurs français
- KwdFr :
- Animaux (MeSH), Animaux de zoo (MeSH), Anticorps antiviraux (sang), Espagne (MeSH), Grippe chez les oiseaux (immunologie), Grippe chez les oiseaux (prévention et contrôle), Oiseaux (MeSH), Protéines de liaison à l'ARN (immunologie), Protéines du core viral (immunologie), Sous-type H5N1 du virus de la grippe A (immunologie), Test ELISA (méthodes), Tests d'inhibition de l'hémagglutination (MeSH), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), Vaccins inactivés (administration et posologie), Vaccins inactivés (immunologie).
- MESH :
- administration et posologie : Vaccins antigrippaux, Vaccins inactivés.
- immunologie : Grippe chez les oiseaux, Protéines de liaison à l'ARN, Protéines du core viral, Sous-type H5N1 du virus de la grippe A, Vaccins antigrippaux, Vaccins inactivés.
- méthodes : Test ELISA.
- prévention et contrôle : Grippe chez les oiseaux.
- sang : Anticorps antiviraux.
- Animaux, Animaux de zoo, Espagne, Oiseaux, Tests d'inhibition de l'hémagglutination.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Animals (MeSH), Animals, Zoo (MeSH), Antibodies, Viral (blood), Birds (MeSH), Enzyme-Linked Immunosorbent Assay (methods), Hemagglutination Inhibition Tests (MeSH), Influenza A Virus, H5N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza in Birds (immunology), Influenza in Birds (prevention & control), RNA-Binding Proteins (immunology), Spain (MeSH), Vaccines, Inactivated (administration & dosage), Vaccines, Inactivated (immunology), Viral Core Proteins (immunology).
- MESH :
- chemical , administration & dosage : Influenza Vaccines, Vaccines, Inactivated.
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Vaccines, Inactivated, Viral Core Proteins.
- geographic : Spain.
- immunology : Influenza A Virus, H5N1 Subtype, Influenza Vaccines, Influenza in Birds, RNA-Binding Proteins.
- methods : Enzyme-Linked Immunosorbent Assay.
- prevention & control : Influenza in Birds.
- Animals, Animals, Zoo, Birds, Hemagglutination Inhibition Tests.
Abstract
In 2005, European Commission directive 2005/744/EC allowed controlled vaccination against avian influenza (AI) virus of valuable avian species housed in zoos. In 2006, 15 Spanish zoos and wildlife centers began a vaccination program with a commercial inactivated H5N9 vaccine. Between November 2007 and May 2008, birds from 10 of these centers were vaccinated again with a commercial inactivated H5N3 vaccine. During these campaigns, pre- and postvaccination samples from different bird orders were taken to study the response against AI virus H5 vaccines. Sera prior to vaccinations with both vaccines were examined for the presence of total antibodies against influenza A nucleoprotein (NP) by a commercial competitive enzyme-linked immunosorbent assay (cELISA). Humoral responses to vaccination were evaluated using a hemagglutination inhibition (HI) assay. In some taxonomic orders, both vaccines elicited comparatively high titers of HI antibodies against H5. Interestingly, some orders, such as Psittaciformes, which did not develop HI antibodies to either vaccine formulation when used alone, triggered notable HI antibody production, albeit in low HI titers, when primed with H5N9 and during subsequent boosting with the H5N3 vaccine. Vaccination with successive heterologous vaccines may represent the best alternative to widely protect valuable and/or endangered bird species against highly pathogenic AI virus infection.
DOI: 10.1128/CVI.00013-11
PubMed: 21430124
PubMed Central: PMC3122527
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comprehensive serological analysis of two successive heterologous vaccines against H5N1 avian influenza virus in exotic birds in zoos.</title><author><name sortKey="Vergara Alert, Julia" sort="Vergara Alert, Julia" uniqKey="Vergara Alert J" first="Júlia" last="Vergara-Alert">Júlia Vergara-Alert</name><affiliation wicri:level="4"><nlm:affiliation>Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. julia.vergara@cresa.uab.cat</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName><orgName type="university">Université autonome de Barcelone</orgName></affiliation></author><author><name sortKey="Fernandez Bellon, Hugo" sort="Fernandez Bellon, Hugo" uniqKey="Fernandez Bellon H" first="Hugo" last="Fernández-Bellon">Hugo Fernández-Bellon</name></author><author><name sortKey="Busquets, Nuria" sort="Busquets, Nuria" uniqKey="Busquets N" first="Núria" last="Busquets">Núria Busquets</name></author><author><name sortKey="Alcantara, Gabriel" sort="Alcantara, Gabriel" uniqKey="Alcantara G" first="Gabriel" last="Alcántara">Gabriel Alcántara</name></author><author><name sortKey="Delclaux, Maria" sort="Delclaux, Maria" uniqKey="Delclaux M" first="María" last="Delclaux">María Delclaux</name></author><author><name sortKey="Pizarro, Bienvenido" sort="Pizarro, Bienvenido" uniqKey="Pizarro B" first="Bienvenido" last="Pizarro">Bienvenido Pizarro</name></author><author><name sortKey="Sanchez, Celia" sort="Sanchez, Celia" uniqKey="Sanchez C" first="Celia" last="Sánchez">Celia Sánchez</name></author><author><name sortKey="Sanchez, Azucena" sort="Sanchez, Azucena" uniqKey="Sanchez A" first="Azucena" last="Sánchez">Azucena Sánchez</name></author><author><name sortKey="Maj, Natalia" sort="Maj, Natalia" uniqKey="Maj N" first="Natàlia" last="Maj">Natàlia Maj</name></author><author><name sortKey="Darji, Ayub" sort="Darji, Ayub" uniqKey="Darji A" first="Ayub" last="Darji">Ayub Darji</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21430124</idno><idno type="pmid">21430124</idno><idno type="doi">10.1128/CVI.00013-11</idno><idno type="pmc">PMC3122527</idno><idno type="wicri:Area/Main/Corpus">00389</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00389</idno><idno type="wicri:Area/Main/Curation">000389</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000389</idno><idno type="wicri:Area/Main/Exploration">000389</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Comprehensive serological analysis of two successive heterologous vaccines against H5N1 avian influenza virus in exotic birds in zoos.</title><author><name sortKey="Vergara Alert, Julia" sort="Vergara Alert, Julia" uniqKey="Vergara Alert J" first="Júlia" last="Vergara-Alert">Júlia Vergara-Alert</name><affiliation wicri:level="4"><nlm:affiliation>Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. julia.vergara@cresa.uab.cat</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName><orgName type="university">Université autonome de Barcelone</orgName></affiliation></author><author><name sortKey="Fernandez Bellon, Hugo" sort="Fernandez Bellon, Hugo" uniqKey="Fernandez Bellon H" first="Hugo" last="Fernández-Bellon">Hugo Fernández-Bellon</name></author><author><name sortKey="Busquets, Nuria" sort="Busquets, Nuria" uniqKey="Busquets N" first="Núria" last="Busquets">Núria Busquets</name></author><author><name sortKey="Alcantara, Gabriel" sort="Alcantara, Gabriel" uniqKey="Alcantara G" first="Gabriel" last="Alcántara">Gabriel Alcántara</name></author><author><name sortKey="Delclaux, Maria" sort="Delclaux, Maria" uniqKey="Delclaux M" first="María" last="Delclaux">María Delclaux</name></author><author><name sortKey="Pizarro, Bienvenido" sort="Pizarro, Bienvenido" uniqKey="Pizarro B" first="Bienvenido" last="Pizarro">Bienvenido Pizarro</name></author><author><name sortKey="Sanchez, Celia" sort="Sanchez, Celia" uniqKey="Sanchez C" first="Celia" last="Sánchez">Celia Sánchez</name></author><author><name sortKey="Sanchez, Azucena" sort="Sanchez, Azucena" uniqKey="Sanchez A" first="Azucena" last="Sánchez">Azucena Sánchez</name></author><author><name sortKey="Maj, Natalia" sort="Maj, Natalia" uniqKey="Maj N" first="Natàlia" last="Maj">Natàlia Maj</name></author><author><name sortKey="Darji, Ayub" sort="Darji, Ayub" uniqKey="Darji A" first="Ayub" last="Darji">Ayub Darji</name></author></analytic><series><title level="j">Clinical and vaccine immunology : CVI</title><idno type="eISSN">1556-679X</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals (MeSH)</term><term>Animals, Zoo (MeSH)</term><term>Antibodies, Viral (blood)</term><term>Birds (MeSH)</term><term>Enzyme-Linked Immunosorbent Assay (methods)</term><term>Hemagglutination Inhibition Tests (MeSH)</term><term>Influenza A Virus, H5N1 Subtype (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (immunology)</term><term>Influenza in Birds (immunology)</term><term>Influenza in Birds (prevention & control)</term><term>RNA-Binding Proteins (immunology)</term><term>Spain (MeSH)</term><term>Vaccines, Inactivated (administration & dosage)</term><term>Vaccines, Inactivated (immunology)</term><term>Viral Core Proteins (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux (MeSH)</term><term>Animaux de zoo (MeSH)</term><term>Anticorps antiviraux (sang)</term><term>Espagne (MeSH)</term><term>Grippe chez les oiseaux (immunologie)</term><term>Grippe chez les oiseaux (prévention et contrôle)</term><term>Oiseaux (MeSH)</term><term>Protéines de liaison à l'ARN (immunologie)</term><term>Protéines du core viral (immunologie)</term><term>Sous-type H5N1 du virus de la grippe A (immunologie)</term><term>Test ELISA (méthodes)</term><term>Tests d'inhibition de l'hémagglutination (MeSH)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (immunologie)</term><term>Vaccins inactivés (administration et posologie)</term><term>Vaccins inactivés (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term><term>Vaccines, Inactivated</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Vaccines, Inactivated</term><term>Viral Core Proteins</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins inactivés</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe chez les oiseaux</term><term>Protéines de liaison à l'ARN</term><term>Protéines du core viral</term><term>Sous-type H5N1 du virus de la grippe A</term><term>Vaccins antigrippaux</term><term>Vaccins inactivés</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H5N1 Subtype</term><term>Influenza Vaccines</term><term>Influenza in Birds</term><term>RNA-Binding Proteins</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Enzyme-Linked Immunosorbent Assay</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Test ELISA</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza in Birds</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe chez les oiseaux</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Animals, Zoo</term><term>Birds</term><term>Hemagglutination Inhibition Tests</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Animaux de zoo</term><term>Espagne</term><term>Oiseaux</term><term>Tests d'inhibition de l'hémagglutination</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In 2005, European Commission directive 2005/744/EC allowed controlled vaccination against avian influenza (AI) virus of valuable avian species housed in zoos. In 2006, 15 Spanish zoos and wildlife centers began a vaccination program with a commercial inactivated H5N9 vaccine. Between November 2007 and May 2008, birds from 10 of these centers were vaccinated again with a commercial inactivated H5N3 vaccine. During these campaigns, pre- and postvaccination samples from different bird orders were taken to study the response against AI virus H5 vaccines. Sera prior to vaccinations with both vaccines were examined for the presence of total antibodies against influenza A nucleoprotein (NP) by a commercial competitive enzyme-linked immunosorbent assay (cELISA). Humoral responses to vaccination were evaluated using a hemagglutination inhibition (HI) assay. In some taxonomic orders, both vaccines elicited comparatively high titers of HI antibodies against H5. Interestingly, some orders, such as Psittaciformes, which did not develop HI antibodies to either vaccine formulation when used alone, triggered notable HI antibody production, albeit in low HI titers, when primed with H5N9 and during subsequent boosting with the H5N3 vaccine. Vaccination with successive heterologous vaccines may represent the best alternative to widely protect valuable and/or endangered bird species against highly pathogenic AI virus infection.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21430124</PMID><DateCompleted><Year>2011</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-679X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>Clinical and vaccine immunology : CVI</Title><ISOAbbreviation>Clin. Vaccine Immunol.</ISOAbbreviation></Journal><ArticleTitle>Comprehensive serological analysis of two successive heterologous vaccines against H5N1 avian influenza virus in exotic birds in zoos.</ArticleTitle><Pagination><MedlinePgn>697-706</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/CVI.00013-11</ELocationID><Abstract><AbstractText>In 2005, European Commission directive 2005/744/EC allowed controlled vaccination against avian influenza (AI) virus of valuable avian species housed in zoos. In 2006, 15 Spanish zoos and wildlife centers began a vaccination program with a commercial inactivated H5N9 vaccine. Between November 2007 and May 2008, birds from 10 of these centers were vaccinated again with a commercial inactivated H5N3 vaccine. During these campaigns, pre- and postvaccination samples from different bird orders were taken to study the response against AI virus H5 vaccines. Sera prior to vaccinations with both vaccines were examined for the presence of total antibodies against influenza A nucleoprotein (NP) by a commercial competitive enzyme-linked immunosorbent assay (cELISA). Humoral responses to vaccination were evaluated using a hemagglutination inhibition (HI) assay. In some taxonomic orders, both vaccines elicited comparatively high titers of HI antibodies against H5. Interestingly, some orders, such as Psittaciformes, which did not develop HI antibodies to either vaccine formulation when used alone, triggered notable HI antibody production, albeit in low HI titers, when primed with H5N9 and during subsequent boosting with the H5N3 vaccine. Vaccination with successive heterologous vaccines may represent the best alternative to widely protect valuable and/or endangered bird species against highly pathogenic AI virus infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vergara-Alert</LastName><ForeName>Júlia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. julia.vergara@cresa.uab.cat</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernández-Bellon</LastName><ForeName>Hugo</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Busquets</LastName><ForeName>Núria</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Alcántara</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Delclaux</LastName><ForeName>María</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pizarro</LastName><ForeName>Bienvenido</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sánchez</LastName><ForeName>Celia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Sánchez</LastName><ForeName>Azucena</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Majó</LastName><ForeName>Natàlia</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Darji</LastName><ForeName>Ayub</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Vaccine Immunol</MedlineTA><NlmUniqueID>101252125</NlmUniqueID><ISSNLinking>1556-679X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C048842">NP protein, Influenza A virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014758">Viral Core Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000836" MajorTopicYN="N">Animals, Zoo</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001717" MajorTopicYN="N">Birds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053124" MajorTopicYN="N">Influenza A Virus, H5N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005585" MajorTopicYN="N">Influenza in Birds</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014758" MajorTopicYN="N">Viral Core Proteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21430124</ArticleId><ArticleId IdType="pii">CVI.00013-11</ArticleId><ArticleId IdType="doi">10.1128/CVI.00013-11</ArticleId><ArticleId IdType="pmc">PMC3122527</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9654-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10920197</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1999 Aug 15;261(1):15-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10484749</ArticleId></ArticleIdList></Reference><Reference><Citation>Avian Pathol. 2004 Oct;33(5):492-505</Citation><ArticleIdList><ArticleId IdType="pubmed">15545029</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Mar;79(5):2814-22</Citation><ArticleIdList><ArticleId IdType="pubmed">15709000</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2005 Dec 30;23(50):5743-50</Citation><ArticleIdList><ArticleId IdType="pubmed">16298028</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18141-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16330777</ArticleId></ArticleIdList></Reference><Reference><Citation>Avian Dis. 2007 Mar;51(1 Suppl):481-3</Citation><ArticleIdList><ArticleId IdType="pubmed">17494614</ArticleId></ArticleIdList></Reference><Reference><Citation>Avian Pathol. 2006 Jun;35(3):189-205</Citation><ArticleIdList><ArticleId IdType="pubmed">16753610</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 Nov 10;24(44-46):6729-33</Citation><ArticleIdList><ArticleId IdType="pubmed">16806601</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2007 Mar 1;359(1):66-71</Citation><ArticleIdList><ArticleId IdType="pubmed">17028058</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 May 10;25(19):3800-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17403559</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2007 May 30;25(22):4345-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17467857</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2006 Jun;80(12):5976-83</Citation><ArticleIdList><ArticleId IdType="pubmed">16731936</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Catalogne</li></region><settlement><li>Barcelone</li></settlement><orgName><li>Université autonome de Barcelone</li></orgName></list><tree><noCountry><name sortKey="Alcantara, Gabriel" sort="Alcantara, Gabriel" uniqKey="Alcantara G" first="Gabriel" last="Alcántara">Gabriel Alcántara</name><name sortKey="Busquets, Nuria" sort="Busquets, Nuria" uniqKey="Busquets N" first="Núria" last="Busquets">Núria Busquets</name><name sortKey="Darji, Ayub" sort="Darji, Ayub" uniqKey="Darji A" first="Ayub" last="Darji">Ayub Darji</name><name sortKey="Delclaux, Maria" sort="Delclaux, Maria" uniqKey="Delclaux M" first="María" last="Delclaux">María Delclaux</name><name sortKey="Fernandez Bellon, Hugo" sort="Fernandez Bellon, Hugo" uniqKey="Fernandez Bellon H" first="Hugo" last="Fernández-Bellon">Hugo Fernández-Bellon</name><name sortKey="Maj, Natalia" sort="Maj, Natalia" uniqKey="Maj N" first="Natàlia" last="Maj">Natàlia Maj</name><name sortKey="Pizarro, Bienvenido" sort="Pizarro, Bienvenido" uniqKey="Pizarro B" first="Bienvenido" last="Pizarro">Bienvenido Pizarro</name><name sortKey="Sanchez, Azucena" sort="Sanchez, Azucena" uniqKey="Sanchez A" first="Azucena" last="Sánchez">Azucena Sánchez</name><name sortKey="Sanchez, Celia" sort="Sanchez, Celia" uniqKey="Sanchez C" first="Celia" last="Sánchez">Celia Sánchez</name></noCountry><country name="Espagne"><region name="Catalogne"><name sortKey="Vergara Alert, Julia" sort="Vergara Alert, Julia" uniqKey="Vergara Alert J" first="Júlia" last="Vergara-Alert">Júlia Vergara-Alert</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000415 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000415 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21430124
|texte= Comprehensive serological analysis of two successive heterologous vaccines against H5N1 avian influenza virus in exotic birds in zoos.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21430124" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |